The protein kinase D1-mediated inflammatory pathway is involved in olanzapine-induced impairment of skeletal muscle insulin signaling in rats
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 270, 119037
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 63 references indexed in Scilit:
- Phosphatidylinositol 3-kinase and protein kinase D1 specifically cooperate to negatively regulate the insulin-like growth factor signaling pathwayBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Altered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in HumansDiabetes, 2011
- Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin ResistanceDiabetes, 2010
- Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 DiabetesDiabetes Care, 2009
- Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal modelSchizophrenia Research, 2009
- Effects of olanzapine on glucose transport, proliferation and survival in C2C12 myoblastsMolecular and Cellular Endocrinology, 2008
- The GLUT4 Glucose TransporterCell Metabolism, 2007
- Inflammation and metabolic disordersNature, 2006
- Olanzapine overdose is associated with acute muscle toxicityHuman & Experimental Toxicology, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006